A Galactose Theory of Parkinson’s Disease
Author:
Preprint
- 22 January 2025
- preprint
- Published by MDPI AG in Preprints.org
Abstract
I present a complete theory of Parkinson’s disease (PD). PD involves an abundance of gut microbiota that degrade mucin, resulting in elevated brain uptake of galactose (a mucin component) and reduced uptake of glucose. Since galactose is not efficiently used for glycolysis, this decreases the production of glutathione, which is essential for countering oxidative iron toxicity. The brain cells that are most sensitive to this effect, as attested by their expression of the iron chelator neuromelanin, are those that continuously secrete dopamine and norepinephrine, and they eventually degenerate. This account explains the etiology, symptoms (including prodromal autonomic symptoms), pathology and risk factors of the disease. The theory is supported by strong evidence, and gives rise to several relatively simply directions for early identification and treatment of the disease.Keywords
All Related Versions
This publication has 7 references indexed in Scilit:
- The pathogenesis of Parkinson's diseaseThe Lancet, 2024
- Possible causes of Parkinson’s diseaseFrontiers in Bioscience-Landmark, 2021
- β2‐adrenoceptor agonists and antagonists and risk of Parkinson's diseaseMovement Disorders, 2018
- Selective neuronal vulnerability in Parkinson diseaseNature Reviews Neuroscience, 2017
- Alpha-Synuclein Function and Dysfunction on Cellular MembranesExperimental Neurobiology, 2014
- α-Synuclein Protects Neurons from Apoptosis Downstream of Free-Radical Production Through Modulation of the MAPK Signalling PathwayNeurotoxicity Research, 2012
- The locus coeruleus and noradrenergic modulation of cognitionNature Reviews Neuroscience, 2009